These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 25724519)
1. miR-137 and miR-197 Induce Apoptosis and Suppress Tumorigenicity by Targeting MCL-1 in Multiple Myeloma. Yang Y; Li F; Saha MN; Abdi J; Qiu L; Chang H Clin Cancer Res; 2015 May; 21(10):2399-411. PubMed ID: 25724519 [TBL] [Abstract][Full Text] [Related]
2. miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF. Sun CY; She XM; Qin Y; Chu ZB; Chen L; Ai LS; Zhang L; Hu Y Carcinogenesis; 2013 Feb; 34(2):426-35. PubMed ID: 23104180 [TBL] [Abstract][Full Text] [Related]
3. MiR-19b and miR-20a suppress apoptosis, promote proliferation and induce tumorigenicity of multiple myeloma cells by targeting PTEN. Yuan J; Su Z; Gu W; Shen X; Zhao Q; Shi L; Jin C; Wang X; Cong H; Ju S Cancer Biomark; 2019; 24(3):279-289. PubMed ID: 30883341 [TBL] [Abstract][Full Text] [Related]
4. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174 [TBL] [Abstract][Full Text] [Related]
5. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Liu Y; Zhang X; Zhang Y; Hu Z; Yang D; Wang C; Guo M; Cai Q Cancer Lett; 2015 Dec; 369(1):58-66. PubMed ID: 26276722 [TBL] [Abstract][Full Text] [Related]
6. miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway. Zhao JJ; Lin J; Zhu D; Wang X; Brooks D; Chen M; Chu ZB; Takada K; Ciccarelli B; Admin S; Tao J; Tai YT; Treon S; Pinkus G; Kuo WP; Hideshima T; Bouxsein M; Munshi N; Anderson K; Carrasco R Cancer Res; 2014 Mar; 74(6):1801-13. PubMed ID: 24599134 [TBL] [Abstract][Full Text] [Related]
8. The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop. Liang HQ; Wang RJ; Diao CF; Li JW; Su JL; Zhang S Oncotarget; 2015 Oct; 6(30):29413-27. PubMed ID: 26320179 [TBL] [Abstract][Full Text] [Related]
9. LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p. Pan Y; Zhang Y; Liu W; Huang Y; Shen X; Jing R; Pu J; Wang X; Ju S; Cong H; Chen H Cell Death Dis; 2019 Feb; 10(2):106. PubMed ID: 30728351 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-26b suppresses tumorigenicity and promotes apoptosis in small cell lung cancer cells by targeting myeloid cell leukemia 1 protein. Yu JG; Ji CH; Shi MH Kaohsiung J Med Sci; 2018 Nov; 34(11):593-605. PubMed ID: 30392566 [TBL] [Abstract][Full Text] [Related]
11. Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence. Di Martino MT; Leone E; Amodio N; Foresta U; Lionetti M; Pitari MR; Cantafio ME; Gullà A; Conforti F; Morelli E; Tomaino V; Rossi M; Negrini M; Ferrarini M; Caraglia M; Shammas MA; Munshi NC; Anderson KC; Neri A; Tagliaferri P; Tassone P Clin Cancer Res; 2012 Nov; 18(22):6260-70. PubMed ID: 23035210 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of miR-320 associated with cancer progression and cell apoptosis via targeting Mcl-1 in cervical cancer. Zhang T; Zou P; Wang T; Xiang J; Cheng J; Chen D; Zhou J Tumour Biol; 2016 Jul; 37(7):8931-40. PubMed ID: 26753959 [TBL] [Abstract][Full Text] [Related]
13. BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia. Xu C; Fu H; Gao L; Wang L; Wang W; Li J; Li Y; Dou L; Gao X; Luo X; Jing Y; Chim CS; Zheng X; Yu L Oncogene; 2014 Jan; 33(1):44-54. PubMed ID: 23208504 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Ji F; Zhang H; Wang Y; Li M; Xu W; Kang Y; Wang Z; Wang Z; Cheng P; Tong D; Li C; Tang H Bone; 2013 Sep; 56(1):220-6. PubMed ID: 23756231 [TBL] [Abstract][Full Text] [Related]
15. A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells. Leotta M; Biamonte L; Raimondi L; Ronchetti D; Di Martino MT; Botta C; Leone E; Pitari MR; Neri A; Giordano A; Tagliaferri P; Tassone P; Amodio N J Cell Physiol; 2014 Dec; 229(12):2106-16. PubMed ID: 24819167 [TBL] [Abstract][Full Text] [Related]
16. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
17. MiR-126 induces myeloma cell line Karpas707 apoptosis by downregulating anti-apoptotic protein MCL. Liu T; Fan HW; Lu S; Wang SQ; Li F Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6873-6879. PubMed ID: 30402852 [TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells. Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931 [TBL] [Abstract][Full Text] [Related]
19. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542 [TBL] [Abstract][Full Text] [Related]
20. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway. Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]